Ambroxol lozenge bioavailability - An open-label, two-way crossover study of the comparative bioavailability of ambroxol lozenges and commercial tablets in healthy Thai volunteers

被引:9
|
作者
Rojpibulstit, M [1 ]
Kasiwong, S [1 ]
Juthong, S [1 ]
Phadoongsombat, N [1 ]
Faroongsarng, D [1 ]
机构
[1] Prince Songkla Univ, Fac Pharmaceut Sci, Songkhla, Thailand
关键词
D O I
10.2165/00044011-200323040-00007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To compare the bioavailability of two 15mg ambroxol lozenges with a commercial 30mg ambroxol tablet. Design: Open-label, two-way crossover study. Method: Each formulation was randomly administered to 20 healthy Thai volunteers (ten male and ten female) with a 1-week washout period between formulations. After administration, serial blood samples were collected over a 24-hour period and the plasma concentration of ambroxol was subsequently measured using high performance liquid chromatography with ultraviolet detection after liquid-liquid extraction. Pharmacokinetic parameters were analysed by a noncompartmental pharmacokinetic model and compared between formulations using analysis of variance with a significance level of 0.05. Results: The point estimates (90% CI) of the area under the plasma concentration-time curve (AUC) and peak plasma concentration (C-max) ratios between lozenge and commercial tablet were 1.07 (0.89 to 1.28) and 1.20 (1.04 to 1.40), respectively. The point estimate (90% CI) of the difference between formulations for time to C-max was 0.40 (-0.20 to 1.00). Conclusion: The two formulations under test were not bioequivalent based on the stipulated bioequivalence criteria. The biclavailability from the ambroxol lozenge might be better, since the 90% CI of the AUC(0-infinity) fell outside the bioequivalence range, and its range was narrower. The difference in rate of absorption was not conclusive because ambroxol was delivered from the lozenge by two parallel processes, namely absorption via oral and gastrointestinal mucosa. The additional oral mucosal absorption might not only contribute more absorption but also introduce variability compared with that of tablet administration. The relative importance of oral versus gastrointestinal mucosal absorption of ambroxol from the lozenge formulation, and the clinical significance of this, requires further study.
引用
下载
收藏
页码:273 / 280
页数:8
相关论文
共 50 条
  • [1] Ambroxol Lozenge BioavailabilityAn Open-Label, Two-Way Crossover Study of the Comparative Bioavailability of Ambroxol Lozenges and Commercial Tablets in Healthy Thai Volunteers
    Malee Rojpibulstit
    Srirat Kasiwong
    Siwasak Juthong
    Narubodee Phadoongsombat
    Damrongsak Faroongsarng
    Clinical Drug Investigation, 2003, 23 : 273 - 280
  • [2] Influence of food on the oral bioavailability of rupatadine tablets in healthy volunteers:: A single-dose, randomized, open-label, two-way crossover study
    Solans, Anna
    Carbo, Marcel-li
    Pena, Juana
    Nadal, Teresa
    Izquierdo, Inaki
    Merlos, Manuel
    CLINICAL THERAPEUTICS, 2007, 29 (05) : 900 - 908
  • [3] Bioavailability of everolimus administered as a single 5 mg tablet versus five 1 mg tablets: a randomized, open-label, two-way crossover study of healthy volunteers
    Thudium, Karen
    Gallo, Jorge
    Bouillaud, Emmanuel
    Sachs, Carolin
    Eddy, Simantini
    Cheung, Wing
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2015, 7 : 11 - 17
  • [4] RANDOMIZED, OPEN-LABEL, SINGLE-DOSE, TWO-WAY CROSSOVER STUDY TO DETERMINE THE RELATIVE BIOAVAILABILITY OF A REFORMULATED LEVOTHYROXINE TABLET COMPARED WITH THE COMMERCIAL TABLET (LEVOXYL®) IN HEALTHY VOLUNTEERS
    Grant, T. M.
    Zhu, Y.
    Brandquist, C.
    Teuscher, N. S.
    Lamson, M. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S95 - S95
  • [5] Relative Bioavailability of Two Formulations of Nevirapine 200-mg Tablets in Healthy Chinese Male Volunteers: A Single-Dose, Randomized-Sequence, Open-Label, Two-Way Crossover Study
    Zhu, Yubing
    Zhang, Qian
    Yu, Cuixia
    Zou, Jianjun
    Yang, Xiaohong
    Hu, Yunfang
    CLINICAL THERAPEUTICS, 2010, 32 (13) : 2258 - 2264
  • [6] An open-label, randomized bioavailability study with alternative methods of administration of crushed ticagrelor tablets in healthy volunteers
    Teng, Renli
    Carlson, Glenn
    Hsia, Judith
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (02) : 182 - 189
  • [7] Bioavailability of Triprolidine as a Single Agent or in Combination With Pseudoephedrine: A Randomized, Open-Label Crossover Study in Healthy Volunteers
    Febbraro, Salvatore
    Shea, Tim
    Cravo, Ana Santos
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (04): : 486 - 495
  • [8] Comparative bioavailability study of two salbutamol tablets in healthy adult volunteers
    Chik, Z.
    Basu, R. C.
    Pendek, R.
    Lee, T. C.
    Mohamed, Z.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2009, 47 (06) : 413 - 418
  • [9] Relative Fasting Bioavailability of Two Formulations of Nateglinide 60 mg in Healthy Male Chinese Volunteers: An Open-Label, Randomized-Sequence, Single-Dose, Two-Way Crossover Study
    Zhu, Yubing
    Zhang, Qian
    Yu, Cuixia
    Chen, Junlin
    Hu, Yunfang
    Zou, Jianjun
    Yuan, Lu
    Ma, Jianhua
    CLINICAL THERAPEUTICS, 2012, 34 (07) : 1505 - 1510
  • [10] AN OPEN-LABEL, RANDOMIZED, CROSSOVER, COMPARATIVE BIOAVAILABILITY STUDY OF LEVODOPA CYCLOPS® AND INBRIJA® IN HEALTHY ADULT SUBJECTS
    Hoppentocht, M.
    Dijkstra, W.
    Grasmeijer, F.
    PARKINSONISM & RELATED DISORDERS, 2024, 122